References
- Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study on a new oral anti-diabetic: N-{ 4-[B-(5-methylpyrazine-2-carboxamido)]-ethyl-benzene sulphonyl }-N'-cyclohexylurea or K4024. Arzneim.-forsch 1971; 21: 2081. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M. M., Tommasini R. Pharmacological study on a new oral anti-diabetic: N-{ 4-[B-(5-methylpyrazine-2-carboxamido)]-ethyl-benzene sulphonyl }-N'-cyclohexylurea or K4024. Arzneim.-forsch 1971; 21: 208
- Artini D., Abbiati R., Orsini G., Parenti M. A., Bloch K., Daturi S., Mandelli V. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. Diabetologia 1973; 9(Suppl.)3112. Artini D., Abbiati R., Orsini G., Parenti M. A., Bloch K., Daturi S., Mandelli V. Pharmacodynamic aspects of two sulphonylurea derivatives glipizide and glibenclamide. Diabetologia 1973; 9(Suppl.)311
- Aumüller W. The development of orally active substances for lowering the blood sugar content. Chem. Ztg 1959; 83: 5773. Aumüller W. The development of orally active substances for lowering the blood sugar content. Chem. Ztg 1959; 83: 577
- Boggiano B. G., Petrow E., Stephenson O., Wild A. M. Hypoglycemic agents Part I. J. Pharm. Pharmacol 1961; 13: 5674. Boggiano B. G., Petrow E., Stephenson O., Wild A. M. Hypoglycemic agents Part I. J. Pharm. Pharmacol 1961; 13: 567
- Franke H., Fuchs J. Ein neues antidiabetisches Prinzip. Ergebnisse klinischer Untersuchungen. Dt. med. Wschr 1955; 80: 14495. Franke H., Fuchs J. Ein neues antidiabetisches Prinzip. Ergebnisse klinischer Untersuchungen. Dt. med. Wschr 1955; 80: 1449
- Goldaniga G. C., Maraone C., Pianezzola E., Valzelli G., Ambrogi V. Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse. Arzneim.-forsch 1973; 23: 2426. Goldaniga G. C., Maraone C., Pianezzola E., Valzelli G., Ambrogi V. Metabolism of glipizide in the rat and dog and its tissue distribution in the mouse. Arzneim.-forsch 1973; 23: 242
- Janbon M., Chaptal J., Vedel A., Schaap J. Accidents hypoglycemiques graves par un sulfamidothiadiazol (le VK 57 ou 2254 RP). Montpell. méd 1942; 21: 4417. Janbon M., Chaptal J., Vedel A., Schaap J. Accidents hypoglycemiques graves par un sulfamidothiadiazol (le VK 57 ou 2254 RP). Montpell. méd 1942; 21: 441
- Loubatikres A. Physiological and pharmacological study of certain sulphonamides causing hypoglycemia. Arch. intern. Physiol 1946; 54: 1748. Loubatikres A. Physiological and pharmacological study of certain sulphonamides causing hypoglycemia. Arch. intern. Physiol 1946; 54: 174
- Loubatières A. The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955. Ann. N. Y. Acad. Sci 1957; 71: 49. Loubatières A. The hypoglycemic sulfonamides: history and development of the problem from 1942 to 1955. Ann. N. Y. Acad. Sci 1957; 71: 4
- Ruschig H., Korger G., Aumüller W., Wagner H., Weyer R., Bänder A., Scholz J. New orally effective blood sugar reducing compounds. Arzneim.-forsch 1958; 8: 44810. Ruschig H., Korger G., Aumüller W., Wagner H., Weyer R., Bänder A., Scholz J. New orally effective blood sugar reducing compounds. Arzneim.-forsch 1958; 8: 448
- Savagnone L. Settim. med 1941; 29: 100511. Savagnone L. Settim. med 1941; 29: 1005